Zobrazeno 1 - 10
of 138
pro vyhledávání: '"AM Dingemans"'
Autor:
Frank Griesinger, Ashis Das-Gupta, J. De Castro Carpeno, AM Dingemans, Vlatka Smoljanovic, Cesare Gridelli, Margarita Donica, Yuichiro Ohe, Francesco Grossi, Corey J. Langer, Kostas N. Syrigos, Nick Thatcher, Jaafar Bennouna
Publikováno v:
Pneumologie. 72:S39-S40
Publikováno v:
Europe PubMed Central
This report describes the validation of a polymerase chain reaction aided transcript titration assay (PATTY) for tumor samples. The results obtained with the PATTY were compared to those of RNase protection in a set of 7 human lung cancer cell lines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a2a4b632a30437c352fc988987bf96e5
http://europepmc.org/abstract/med/11131661
http://europepmc.org/abstract/med/11131661
Publikováno v:
Europe PubMed Central
A 35-year-old man presented with a brief history of haemorrhagic diarrhoea. He had moved to The Netherlands 24 years before and had been in Surinam 12 years ago for the last time. Physical examination and routine laboratory tests revealed no abnormal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0df051b74f197831bdfb3d1ad8f5dc65
http://europepmc.org/abstract/med/15495993
http://europepmc.org/abstract/med/15495993
Autor:
Mathian É; Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France; Department of Mathematics and Informatics, Ecole Centrale de Lyon, Lyon, France., Drouet Y; UMR CNRS 5558 LBBE, Claude Bernard Lyon 1 University, Villeurbanne, France; Prevention & Public Health Department, Centre Léon Bérard, Lyon, France., Sexton-Oates A; Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France., Papotti MG; Department of Oncology, University of Turin, Turin, Italy., Pelosi G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Vignaud JM; Department of Biopathology, Institut De Cancérologie de Lorraine (CHRU-ICL), Vandoeuvre-lès-Nancy, France; University Hospital of Nancy (CHRU), Nancy, France., Brcic L; Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria., Mansuet-Lupo A; Department of Pathology, Hôpital Cochin, AP-HP, Université de Paris, Paris, France., Damiola F; Department of Biopathology, Centre Léon Bérard & Pathology Research Platform, Cancer Research Center of Lyon, Lyon, France., Altun C; Department of Biopathology, Centre Léon Bérard & Pathology Research Platform, Cancer Research Center of Lyon, Lyon, France., Berthet JP; Department of Thoracic Surgery, FHU OncoAge, Nice Pasteur Hospital, University Cote d'Azur, Nice, France., Fournier CB; Caen Lower Normandy Tumour Bank, Centre François Baclesse, Caen, France., Brustugun OT; Section of Oncology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Centonze G; First Pathology Division, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Chalabreysse L; Hospices Civils de Lyon, GHE, Institut de Pathologie Est, Bron, France., de Montpréville VT; Department of Pathology, Hôpital Marie-Lannelongue, Groupe Hospitalier Paris Saint Joseph, Le Plessis Robinson, France., di Micco CM; Unit of Oncology, Fondazione IRCCS Cas Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Fadel E; Department of Pathology, Hôpital Marie-Lannelongue, Groupe Hospitalier Paris Saint Joseph, Le Plessis Robinson, France; Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Université Paris-Saclay, Le Plessis-Robinson, France., Gadot N; Department of Biopathology, Centre Léon Bérard & Pathology Research Platform, Cancer Research Center of Lyon, Lyon, France., Graziano P; Unit of Oncology, Fondazione IRCCS Cas Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Hofman P; FHU OncoAge, Biobank BB-0033-0025, Laboratory of Clinical and Experimental Pathology, Nice Pasteur Hospital, University Cote d'Azur, Nice, France., Hofman V; FHU OncoAge, Biobank BB-0033-0025, Laboratory of Clinical and Experimental Pathology, Nice Pasteur Hospital, University Cote d'Azur, Nice, France., Lacomme S; University Hospital of Nancy (CHRU), Nancy, France., Lund-Iversen M; Department of Pathology, Oslo University Hospital, Oslo, Norway., Mangiante L; Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France; School of Medicine, Stanford University, Stanford, USA., Milione M; First Pathology Division, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Muscarella LA; Unit of Oncology, Fondazione IRCCS Cas Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Perrin C; Hospices Civils de Lyon, GHE, Institut de Pathologie Est, Bron, France., Planchard G; Pathology Department, Caen University Hospital, Normandy University, Caen, France., Popper H; Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria., Rousseau N; Caen Lower Normandy Tumour Bank, Centre François Baclesse, Caen, France., Roz L; Tumor Genomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Sabella G; First Pathology Division, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tabone-Eglinger S; Biological Resource Center, Centre Léon Bérard, Lyon, France., Voegele C; Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France., Volante M; Department of Oncology, University of Turin, Turin, Italy., Walter T; Service d'Oncologie Médicale, Groupement Hospitalier Centre, Institut de Cancérologie des Hospices Civils de Lyon, Lyon, France., Dingemans AM; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Moonen L; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, Netherlands., Speel EJ; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, Netherlands., Derks J; Department of Pulmonary Diseases, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., Girard N; Institut Curie, Versailles, France., Chen L; Department of Mathematics and Informatics, Ecole Centrale de Lyon, Lyon, France; Institut Universitaire de France (IUF), Paris, France., Alcala N; Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France., Fernandez-Cuesta L; Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France. Electronic address: fernandezcuestal@iarc.who.int., Lantuejoul S; Department of Biopathology, Centre Léon Bérard & Pathology Research Platform, Cancer Research Center of Lyon, Lyon, France., Foll M; Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
Publikováno v:
ESMO open [ESMO Open] 2024 Jun; Vol. 9 (6), pp. 103591. Date of Electronic Publication: 2024 Jun 14.
Autor:
Schoenmaekers J; Department of Pulmonary Diseases, GROW - School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands., Dijkstra J; Department of Medical Psychology, Maastricht University Medical Center+, Maastricht, the Netherlands., van der Wekken A; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Paats M; Department Pulmonary Diseases, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., Broen M; Department of Neurology, Maastricht University Medical Center+, Maastricht, the Netherlands., Brandts L; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Center +, Maastricht, the Netherlands., Dingemans AM; Department Pulmonary Diseases, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., Hendriks L; Department of Pulmonary Diseases, GROW - School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands. Electronic address: Lizza.hendriks@mumc.nl.
Publikováno v:
Clinical lung cancer [Clin Lung Cancer] 2024 Mar; Vol. 25 (2), pp. 168-174.e1. Date of Electronic Publication: 2023 Dec 13.
Autor:
Dayton TL; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, 3584 CT Utrecht, the Netherlands; Oncode Institute, Hubrecht Institute, 3584 CT Utrecht, the Netherlands. Electronic address: talya.dayton@embl.es., Alcala N; Rare Cancers Genomics Team (RCG), Genomic Epidemiology Branch (GEM), International Agency for Research on Cancer/World Health Organisation (IARC/WHO), 69007 Lyon, France., Moonen L; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, 6229 ER Maastricht, the Netherlands., den Hartigh L; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, 3584 CT Utrecht, the Netherlands., Geurts V; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, 3584 CT Utrecht, the Netherlands., Mangiante L; Rare Cancers Genomics Team (RCG), Genomic Epidemiology Branch (GEM), International Agency for Research on Cancer/World Health Organisation (IARC/WHO), 69007 Lyon, France., Lap L; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, 6229 ER Maastricht, the Netherlands., Dost AFM; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, 3584 CT Utrecht, the Netherlands; Oncode Institute, Hubrecht Institute, 3584 CT Utrecht, the Netherlands., Beumer J; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, 3584 CT Utrecht, the Netherlands; Oncode Institute, Hubrecht Institute, 3584 CT Utrecht, the Netherlands., Levy S; Department of Medical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., van Leeuwaarde RS; Department of Endocrine Oncology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands., Hackeng WM; Department of Pathology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, the Netherlands., Samsom K; Department of Pathology, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., Voegele C; Rare Cancers Genomics Team (RCG), Genomic Epidemiology Branch (GEM), International Agency for Research on Cancer/World Health Organisation (IARC/WHO), 69007 Lyon, France., Sexton-Oates A; Rare Cancers Genomics Team (RCG), Genomic Epidemiology Branch (GEM), International Agency for Research on Cancer/World Health Organisation (IARC/WHO), 69007 Lyon, France., Begthel H; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, 3584 CT Utrecht, the Netherlands., Korving J; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, 3584 CT Utrecht, the Netherlands., Hillen L; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, 6229 ER Maastricht, the Netherlands., Brosens LAA; Department of Pathology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, the Netherlands., Lantuejoul S; Department of Biopathology, Pathology Research Platform- Synergie Lyon Cancer- CRCL, Centre Léon Bérard Unicancer, 69008 Lyon, France; Université Grenoble Alpes, Grenoble, France., Jaksani S; Hubrecht Organoid Technology, Utrecht 3584 CM, the Netherlands., Kok NFM; Department of Surgery, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., Hartemink KJ; Department of Surgery, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., Klomp HM; Department of Surgery, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., Borel Rinkes IHM; Department of Endocrine Surgical Oncology, University Medical Center Utrecht, Utrecht 3508 GA, the Netherlands., Dingemans AM; Department of Pulmonary Diseases, GROW School for Oncology and and Reproduction, Maastricht University Medical Centre, Maastricht, the Netherlands; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam 3015 GD, the Netherlands., Valk GD; Department of Endocrine Oncology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands., Vriens MR; Department of Endocrine Surgical Oncology, University Medical Center Utrecht, Utrecht 3508 GA, the Netherlands., Buikhuisen W; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., van den Berg J; Department of Pathology, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., Tesselaar M; Department of Medical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Derks J; Department of Pulmonary Diseases, GROW School for Oncology and and Reproduction, Maastricht University Medical Centre, Maastricht, the Netherlands., Speel EJ; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, 6229 ER Maastricht, the Netherlands., Foll M; Rare Cancers Genomics Team (RCG), Genomic Epidemiology Branch (GEM), International Agency for Research on Cancer/World Health Organisation (IARC/WHO), 69007 Lyon, France., Fernández-Cuesta L; Rare Cancers Genomics Team (RCG), Genomic Epidemiology Branch (GEM), International Agency for Research on Cancer/World Health Organisation (IARC/WHO), 69007 Lyon, France. Electronic address: fernandezcuestal@iarc.who.int., Clevers H; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, 3584 CT Utrecht, the Netherlands; Oncode Institute, Hubrecht Institute, 3584 CT Utrecht, the Netherlands. Electronic address: h.clevers@hubrecht.eu.
Publikováno v:
Cancer cell [Cancer Cell] 2023 Dec 11; Vol. 41 (12), pp. 2083-2099.e9.
Autor:
Dingemans AM; Department of Pulmonology, Erasmus Medical Center Cancer Institute, 3015 CN Rotterdam, The Netherlands., van Walree N; Department of Pulmonary Diseases, Amphia Hospital, 4818 CK Breda, The Netherlands., Schramel F; Department of Pulmonary Diseases, St. Antonius Hospital, 3435 CM Nieuwegein, The Netherlands., Soud MY; Department of Pulmonary Diseases, Máxima Medisch Centrum, 5504 DB Veldhoven, The Netherlands., Baltruškevičienė E; Department of Medical Oncology, National Cancer Institute, 08406 Vilnius, Lithuania., Lybaert W; Department of Medical Oncology, VITAZ, 9100 Sint-Niklaas, Belgium., Veldhorst M; Nutricia Research, 3584 CT Utrecht, The Netherlands., van den Berg CA; Nutricia Research, 3584 CT Utrecht, The Netherlands., Kaasa S; Department of Oncology, Oslo University Hospital, 0379 Oslo, Norway.
Publikováno v:
Nutrients [Nutrients] 2023 Dec 07; Vol. 15 (24). Date of Electronic Publication: 2023 Dec 07.
Autor:
Tohidinezhad F; Department of Radiation Oncology (Maastro Clinic), School for Oncology and Reproduction (GROW), Maastricht University Medical Center, Maastricht, the Netherlands., Bontempi D; Department of Radiation Oncology (Maastro Clinic), School for Oncology and Reproduction (GROW), Maastricht University Medical Center, Maastricht, the Netherlands; Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands., Zhang Z; Department of Radiation Oncology (Maastro Clinic), School for Oncology and Reproduction (GROW), Maastricht University Medical Center, Maastricht, the Netherlands., Dingemans AM; Department of Pulmonary Diseases, School for Oncology and Reproduction (GROW), Maastricht University Medical Center, Maastricht, the Netherlands., Aerts J; Department of Pulmonary Medicine, School of Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Bootsma G; Department of Pulmonary Diseases, Zuyderland Hospital, Heerlen, the Netherlands., Vansteenkiste J; Department of Respiratory Oncology, University Hospital KU Leuven, Leuven, Belgium., Hashemi S; Department of Pulmonary Medicine, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands., Smit E; Netherlands Cancer Institute, Amsterdam, the Netherlands., Gietema H; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands., Aerts HJ; Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands; Departments of Radiation Oncology and Radiology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Dekker A; Department of Radiation Oncology (Maastro Clinic), School for Oncology and Reproduction (GROW), Maastricht University Medical Center, Maastricht, the Netherlands., Hendriks LEL; Department of Pulmonary Diseases, School for Oncology and Reproduction (GROW), Maastricht University Medical Center, Maastricht, the Netherlands., Traverso A; Department of Radiation Oncology (Maastro Clinic), School for Oncology and Reproduction (GROW), Maastricht University Medical Center, Maastricht, the Netherlands., De Ruysscher D; Department of Radiation Oncology (Maastro Clinic), School for Oncology and Reproduction (GROW), Maastricht University Medical Center, Maastricht, the Netherlands. Electronic address: dirk.deruysscher@maastro.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Apr; Vol. 183, pp. 142-151. Date of Electronic Publication: 2023 Feb 09.
Autor:
Whisenant JG; Vanderbilt University Medical Center, Nashville, Tennessee., Baena J; Hospital Universitario 12 de Octubre, Madrid, Spain., Cortellini A; Department of Surgery and Cancer, Imperial College London, London, United Kingdom. Electronic address: a.cortellini@imperial.ac.uk., Huang LC; Vanderbilt University Medical Center, Nashville, Tennessee., Lo Russo G; Thoracic Oncology Unit, Medical Oncology Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy., Porcu L; Oncology Department, Istituto di Ricerche Farmacologiche Mario Negri Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy., Wong SK; Vanderbilt University Medical Center, Nashville, Tennessee., Bestvina CM; Department of Medicine, University of Chicago Comprehensive Cancer Center, University of Chicago, Chicago, Illinois., Hellmann MD; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Roca E; Thoracic Oncology-Lung Unit, Ospedale Pederzoli, Peschiera d/G, Verona, Italy., Rizvi H; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Monnet I; Service de Pneumologie, Centre Hospitalier Intercommunal de Créteil, Créteil, France., Boudjemaa A; Service de Pneumologie, Centre Hospitalier Intercommunal de Créteil, Créteil, France., Rogado J; Seccion de Oncologia Medica, Hospital Universitario Infanta Leonor, Madrid, Spain., Pasello G; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy; Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy., Leighl NB; Division of Medical Oncology/Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada., Arrieta O; Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), México City, México., Aujayeb A; Respiratory Department, Northumbria Healthcare NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom., Batra U; Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India., Azzam AY; Faculty of Medicine, October 6 University, Giza, Egypt., Unk M; Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Azab MA; KasrAlAiny School of Medicine, Cairo University, El Cairo, Egypt., Zhumagaliyeva AN; Semey Medical University, Center for Nuclear Medicine and Oncology of Semey, Semey, Kazakhstan., Gomez-Martin C; Hospital Universitario 12 de Octubre, Madrid, Spain., Blaquier JB; Thoracic Oncology Section, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina., Geraedts E; Groene Hart Ziekenhuis, Gouda, The Netherlands., Mountzios G; Fourth Department of Medical Oncology and Clinical Trials Unit, Henry Dunant Hospital Center, Athens, Greece., Serrano-Montero G; Seccion de Oncologia Medica, Hospital Universitario Infanta Leonor, Madrid, Spain., Reinmuth N; Asklepios Kliniken GmbH, Asklepios Fachkliniken Muenchen, Gauting, Germany., Coate L; Cancer Trials Ireland, Dublin, Ireland; Mid-Western Cancer Centre, University Hospital Limerick, Limerick, Ireland., Marmarelis M; Division of Hematology and Oncology, Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Presley CJ; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Hirsch FR; Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine Mount Sinai, New York, New York., Garrido P; IRYCIS, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Madrid, Spain., Khan H; The Warren Alpert Medical School of Brown University, Providence, Rhode Island., Baggi A; Medical Oncology Unit, Department of Medical-Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia at ASST-Spedali Civili, Brescia, Italy., Mascaux C; Service De Pneumologie, Hôpitaux Universitaires De Strasbourg, Strasbourg, France; Université De Strasbourg, Inserm UMR_S 1113, IRFAC, Laboratory Streinth (Stress REsponse and INnovative THerapy against Cancer), ITI InnoVec, Strasbourg, France., Halmos B; Division of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York., Ceresoli GL; Department of Medical Oncology, Cliniche Humanitas Gavazzeni, Bergamo, Italy., Fidler MJ; Department of Hematology, Oncology, and Cell Therapy, Rush University Medical Center, Chicago, Illinois., Scotti V; Department of Oncology, Radiation Therapy Unit, Careggi University Hospital, Florence, Italy., Métivier AC; Department of Pneumology, Hôpital Foch, Suresnes, France., Falchero L; Service de Pneumologie et Cancérologie Thoracique, L'Hôpital Nord-Ouest, Villefranche S/S, France., Felip E; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Genova C; UO Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; Dipartimento di Medicina Interna e Specialità Mediche (DIMI), Università degli Studi di Genova, Genoa, Italy., Mazieres J; Toulouse University Hospital, Institut Universitaire du Cancer, Université Paul Sabatier, Toulouse, France., Tapan U; Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts., Brahmer J; Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland., Bria E; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Medical Oncology, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy., Puri S; Division of Medical Oncology, The Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah., Popat S; Lung Unit, Royal Marsden National Health Service Foundation Trust, London, United Kingdom; The Institute of Cancer Research, London, United Kingdom., Reckamp KL; Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California., Morgillo F; Department of Precision Medicine, Medical Oncology and Haematology, Università degli studi della Campania L. Vanvitelli, Naples, Italy., Nadal E; Thoracic Oncology Unit, Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain., Mazzoni F; Medical Oncology, Careggi University Hospital, Florence, Italy., Agustoni F; Medical Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia, Italy., Bar J; Institute of Oncology, Sheba Medical Center, Tel HaShomer, Ramat Gan, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Grosso F; Mesothelioma and Rare Cancer Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Avrillon V; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Patel JD; Division of Hematology and Oncology, Northwestern University, Chicago, Illinois., Gomes F; Medical Oncology Department, The Christie NHS Foundation Trust, Manchester, United Kingdom., Ibrahim E; The Clatterbridge Cancer Center NHS Foundation Trust, Birkenhead, United Kingdom., Trama A; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy., Bettini AC; Medical Oncology Department, ASST Papa Giovanni XXIII, Bergamo, Italy., Barlesi F; Gustave Roussy Institute, Villejuif, Aix Marseille University, Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche en Cancérologie de Marseille (CRCM), Marseille, France., Dingemans AM; Erasmus University Medical Center, Rotterdam, University Maastricht, Maastricht, The Netherlands., Wakelee H; Stanford Cancer Institute, Stanford University, Stanford, California., Peters S; Lausanne University Hospital, Lausanne University, Lausanne, Switzerland., Horn L; Vanderbilt University Medical Center, Nashville, Tennessee., Garassino MC; Department of Medicine, University of Chicago Comprehensive Cancer Center, University of Chicago, Chicago, Illinois., Torri V; Oncology Department, Istituto di Ricerche Farmacologiche Mario Negri Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2022 May; Vol. 17 (5), pp. 661-674. Date of Electronic Publication: 2022 Feb 01.
Autor:
Passaro A; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan, Italy. Electronic address: antonio.passaro@ieo.it., Leighl N; Division of Medical Oncology/Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Canada., Blackhall F; Division of Cancer Sciences, The University of Manchester, Manchester, UK; Department of Medical Oncology, The Christie National Health Service (NHS) Foundation Trust, Manchester, UK., Popat S; National Heart and Lung Institute, Imperial College, London, UK; Lung Unit, Royal Marsden Hospital, London, UK; The Institute of Cancer Research, London, UK., Kerr K; Aberdeen Royal Infirmary, Aberdeen University Medical School, Aberdeen, UK., Ahn MJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Arcila ME; Department of Pathology, Molecular Diagnostics Service, Memorial Sloan Kettering Cancer Center, New York, USA., Arrieta O; Thoracic Oncology Unit, Instituto Nacional de Cancerología, Mexico City, Mexico., Planchard D; Department of Medical Oncology, Gustave Roussy, Villejuif, France., de Marinis F; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan, Italy., Dingemans AM; Department of Respiratory Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Dziadziuszko R; Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdansk, Poland., Faivre-Finn C; The University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK., Feldman J; Lung Cancer Patient and Advocate, Co-Founder of EGFR Resisters Patient Group., Felip E; Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Curigliano G; Department of Oncology and Hemato-Oncology, University of Milano, European Institute of Oncology IRCCS, Milan, Italy., Herbst R; Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA., Jänne PA; Lowe Center for Thoracic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA., John T; Peter MacCallum Cancer Centre, Melbourne, Australia., Mitsudomi T; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan., Mok T; State Key Laboratory of Translational Oncology, Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region, Hong Kong, China., Normanno N; Cell Biology and Biotherapy and Scientific Directorate, Istituto Nazionale Tumori, 'Fondazione G.Pascale' IRCCS, Naples, Italy., Paz-Ares L; Lung Cancer Clinical Research Unit, and Complutense University, Madrid, Spain., Ramalingam S; Department of Hematology and Medical Oncology, Winship Cancer Institute, Atlanta, Georgia., Sequist L; Department of Medicine, Massachusetts General Hospital, Boston, USA., Vansteenkiste J; Department of Respiratory Oncology, University Hospital KU Leuven, Leuven, Belgium., Wistuba II; Department of Translational Molecular Pathology, Unit 951, The University of Texas MD Anderson Cancer Center, Houston, USA., Wolf J; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany., Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangdong, China., Yang SR; The Institute of Cancer Research, London, UK., Yang JCH; Department of Oncology, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Republic of China., Yatabe Y; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Pentheroudakis G; Department of Medical Oncology, University of Ioannina, Ioannina, Epirus, Greece., Peters S; Oncology Department - CHUV, Lausanne University, Lausanne, Switzerland.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2022 May; Vol. 33 (5), pp. 466-487. Date of Electronic Publication: 2022 Feb 14.